- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03844204
Effect of a Servo-control System on Heat Loss in Very Low Birth Weight Infants at Birth (SCOPRI)
Effect of a Servo-control System on Heat Loss in Very Low Birth Weight Infants at Birth: a Multicenter, Prospective, Randomized Controlled Trial
Hypothermia in preterm infants during the immediate postnatal phase is associated with morbidity and mortality and remains an unresolved, worldwide challenge.
A list of interventions, including adequate room temperature, use of infant warmers, polyethylene bags/wrap, pre-heated mattresses, caps and heated and humidified gases, to prevent thermal loss at birth in very preterm infants has been recommended, but a certain percentage of very preterm infants are hypothermic at the time of the neonatal intensive care unit (NICU) admission suggesting that further measures are needed. The thermal servo-controlled systems are routinely used in the NICU to accurately manage the patients' temperature, but their role during the immediate postnatal phase has not been previously assessed.
We hypothesized that using a thermal servo-control system at delivery could prevent heat loss during this delicate phase and increase the percentage of very low birth weight infants (VLBWI) in the normal thermal range (temperature 36.5-37.5°C) at NICU admission. The aim of this study will be to compare two modes of thermal management (with and without the use of a thermal servo-controlled system) for preventing heat loss at birth in VLBWI infants.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Padova, Italy, 35128
- University of Padova
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Estimated birth weight <1500 g and/or gestational age <30+6 weeks (and)
- Inborn (and)
- Parental consent
Exclusion Criteria:
- Major congenital malformations (i.e. cardiac disease, defects of abdominal wall, ...);
- Outborn;
- Parental refusal to participate to the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Servo-controlled system
The temperature probe of the servo-controlled system will be positioned on the patient's abdomen with an adhesive tape.
The body temperature will be set at 37°C.
|
All patients will be positioned under the infant warmer.
In the treatment group, a probe positioned on the skin of the neonate will guide the thermal exposure in a servo-controlled modality.
In the control group, thermal exposure will be determined manually by setting the power of the heater at the maximum output.
|
Active Comparator: No servo-controlled system
The temperature of the infant warmer will be manually set at maximum of power output.
|
All patients will be positioned under the infant warmer.
In the treatment group, a probe positioned on the skin of the neonate will guide the thermal exposure in a servo-controlled modality.
In the control group, thermal exposure will be determined manually by setting the power of the heater at the maximum output.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Proportion of neonates in the normal thermal range (temperature 36.5-37.5°C) at NICU admission
Time Frame: 30 minutes
|
30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Proportion of neonates with temperature less than 36.0°C at NICU admission
Time Frame: 30 minutes
|
30 minutes
|
Proportion of neonates with mild hypothermia (temperature 36.0-36.4°C) at NICU admission
Time Frame: 30 minutes
|
30 minutes
|
Proportion of hyperthermic neonates (temperature >38.0°C) at NICU admission
Time Frame: 30 minutes
|
30 minutes
|
Temperature at 1 hour after NICU admission
Time Frame: 1 hour
|
1 hour
|
Proportion of ineonates with ntraventricular hemorrhage (grade I-IV)
Time Frame: 7 days
|
7 days
|
Propoertions of neoantes with respiratory distress syndrome
Time Frame: 3 days
|
3 days
|
Proportion of neonates with late onset sepsis
Time Frame: 14 days
|
14 days
|
Proportion of neonates with bronchopulmonary dysplasia
Time Frame: 36 gestational weeks
|
36 gestational weeks
|
Proportion of deaths
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4371/AO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neonatal Hypothermia
-
Boston Children's HospitalHarvard Medical School (HMS and HSDM); Brigham and Women's Hospital; Ministry... and other collaboratorsCompleted
-
Aliona Vilinsky-RedmondCompletedNeonatal HypothermiaIreland
-
William Marsh Rice UniversityKamuzu University of Health SciencesRecruiting
-
William Marsh Rice UniversityKamuzu University of Health SciencesRecruiting
-
William Marsh Rice UniversityUniversity of Lagos, NigeriaRecruiting
-
William Marsh Rice UniversityIfakara Health Institute; Muhimbili University of Health and Allied Sciences; Ministry of Health, Community Development, Gender, Elderly, and Children (MOHCDGEC)Recruiting
-
Boston Children's HospitalHarvard Medical School (HMS and HSDM); Ministry of Health, Rwanda; Partners in... and other collaboratorsUnknownHypothermia NeonatalRwanda
-
Thayyil, SudhinWayne State UniversityActive, not recruitingNeonatal Encephalopathy | Magnetic Resonance Spectroscopy | Hypothermia NeonatalUnited Kingdom, United States, Italy
-
Princess Anna Mazowiecka Hospital, Warsaw, PolandRecruitingPerinatal Asphyxia | Hypothermia Neonatal | Haemodynamic InstabilityPoland
-
University of South CarolinaGhana Health Services; Korle-Bu Teaching Hospital, Accra, Ghana; Centre for Learning...Not yet recruiting
Clinical Trials on Thermal servo-controlled system
-
ResMedCompletedCheyne-Stokes Respiration | Periodic BreathingGermany
-
Unity Health TorontoCompletedRespiratory Insufficiency | Respiration, ArtificialCanada
-
Philips RespironicsCompleted
-
Swiss Group for Clinical Cancer ResearchImmunophotonics, Inc.RecruitingAdvanced Solid TumorsSwitzerland
-
M.D. Anderson Cancer CenterBioTex, Inc.Terminated
-
Chinese PLA General HospitalActive, not recruiting
-
Kaohsiung Medical University Chung-Ho Memorial...National Science Council, Taiwan; Kaohsiung Medical University; National Health...Completed
-
National Cancer Institute (NCI)Completed
-
Johnson & Johnson Surgical Vision, Inc.CompletedCataracts | Meibomian Gland Dysfunction (MGD)United States
-
Apsara Medical CorporationCompleted